Charlie Kimball, Veteran Indy Race Car Driver Talks About Life In The Fast Lane with T1D

For Charlie Kimball, a professional Indy race car driver, there’s no place he’d rather be than in a racecar. “I love the …

AADE Rebrands as Association of Diabetes Care & Education Specialists (ADCES)

The American Association of Diabetes Educators announced that the organization has changed its name to reflect the association’s shift to a …

FDA approves Ozempic® for Heart Problems in Adults with T2D

The U.S. Food and Drug Administration (FDA) has approved a new indication for Novo Nordisk’s Ozempic® (semaglutide) injection 0.5 mg or 1 mg …

Tandem Launches the t:slim X2 Insulin Pump with Control-IQ Tech. in the U.S.

Tandem Diabetes Care, Inc. today announced the commercial launch of the t:slim X2™ insulin pump with Control-IQ™ technology, an …

Lilly Expands Affordability With Lower-Priced Versions of Popular Insulin

Eli Lilly today announced plans to add two more cost-saving options to its suite of solutions for people who use Lilly insulin. The company plans to …

Researchers Find Way to Distinguish Type 1 Diabetes from Type 1.5 Diabetes

A multi-center team of researchers led by Children’s Hospital of Philadelphia (CHOP) has discovered a genetic signature that could help …

Bigfoot Biomedical Gets $45M Financing, will Support Completion of Unity™ Program

Bigfoot Biomedical, a medical device company creating insulin delivery through the use of AI and automation announced it has raised $45 million in …

New Year’s Resolutions and Diabetes: 4 Steps to Setting Attainable Goals

By: Laurie Block, MS, RDN, CDE. Edited by: Suvarna Sheth. When it comes to making New Year’s resolutions it’s important to realize that change is …

Novo Nordisk’s Launches New Insulin Affordability Offerings in the U.S.

Novo Nordisk launched a handful of new insulin affordability offerings for people living in the U.S. The new offerings include: My$99Insulin: …

FDA Approves Novo Nordisk’s Fiasp® for Children with Diabetes

The U.S. Food and Drug Administration (FDA) has approved Novo Nordisk’s Fiasp® (insulin aspart injection) 100 u/mL for use as a new mealtime …